|
COPYRIGHT 2002 International Medical News Group
BETHESDA, M D. -- Endoscopic retrograde cholangiopancreatography remains a mainstay in the treatment of many pancreatic and hepatobiliary diseases but its role as a diagnostic modality is diminishing as less invasive imaging techniques emerge.
That was the conclusion of an independent, expert panel convened by the National Institutes of Health. The panel recommended endoscopic retrograde cholangiopancreatography (ERCP) for the treatment of symptomatic gallstone disease, common bile duct stones, recurrent pancreatitis, and pancreatic pseudocysts. ERCP with...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
